Msn Labs Pvt Ltd Company Profile
What is the competitive landscape for MSN LABS PVT LTD
MSN LABS PVT LTD has two approved drugs.
There are six tentative approvals on MSN LABS PVT LTD drugs.
Drugs and US Patents for Msn Labs Pvt Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msn Labs Pvt Ltd | AZACITIDINE | azacitidine | POWDER;INTRAVENOUS, SUBCUTANEOUS | 212580-001 | May 16, 2024 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Msn Labs Pvt Ltd | LACOSAMIDE | lacosamide | TABLET;ORAL | 204921-003 | Mar 17, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Msn Labs Pvt Ltd | LACOSAMIDE | lacosamide | TABLET;ORAL | 204921-002 | Mar 17, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

